Follow
Mireia Camós
Mireia Camós
MD, PhD, Hospital Sant Joan de Deu/ Group Coordinator, Leukemia and other pediatric hemopathies
Verified email at hsjdbcn.org - Homepage
Title
Cited by
Cited by
Year
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone
AL Feldman, DA Arber, S Pittaluga, A Martinez, JS Burke, M Raffeld, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5433-5439, 2008
3342008
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post …
M Pratcorona, S Brunet, J Nomdedéu, JM Ribera, M Tormo, R Duarte, ...
Blood, The Journal of the American Society of Hematology 121 (14), 2734-2738, 2013
3102013
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
S Mercadal, J Briones, B Xicoy, C Pedro, L Escoda, C Estany, M Camos, ...
Annals of Oncology 19 (5), 958-963, 2008
2402008
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive …
E Giné, A Martinez, N Villamor, A López-Guillermo, M Camos, D Martinez, ...
Haematologica 95 (9), 1526, 2010
2132010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive …
E Giné, A Martinez, N Villamor, A López-Guillermo, M Camos, D Martinez, ...
Haematologica 95 (9), 1526, 2010
2112010
Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome
A Garcia-Herrera, L Colomo, M Camós, J Carreras, O Balague, ...
Journal of clinical oncology 26 (20), 3364-3371, 2008
1662008
Gene Expression Profiling of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13) and MYST3-CREBBP Rearrangement Reveals a Distinctive Signature with a …
M Camós, J Esteve, P Jares, D Colomer, M Rozman, N Villamor, D Costa, ...
Cancer research 66 (14), 6947-6954, 2006
1652006
Premature aging and immune senescence in HIV-infected children
K Gianesin, A Noguera-Julian, M Zanchetta, P Del Bianco, MR Petrara, ...
Aids 30 (9), 1363-1373, 2016
982016
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ...
Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019
972019
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation
M Rozman, M Camós, D Colomer, N Villamor, J Esteve, D Costa, A Carrió, ...
Genes, Chromosomes and Cancer 40 (2), 140-145, 2004
972004
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
S Montoto, A Lopez-Guillermo, A Altes, G Perea, A Ferrer, M Camós, ...
Annals of oncology 15 (10), 1484-1489, 2004
952004
Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free …
F Cervantes, JC Hernández-Boluda, JL Steegmann, E Conde, ...
haematologica 88 (10), 1117-1122, 2003
812003
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy
E Barragán, P Montesinos, M Camos, M González, MJ Calasanz, ...
Haematologica 96 (10), 1470, 2011
742011
ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia
M Crespo, N Villamor, E Giné, A Muntañola, D Colomer, T Marafioti, ...
Clinical cancer research 12 (3), 726-734, 2006
712006
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
M Maffioli, M Camós, A Gaya, JC Hernández-Boluda, A Álvarez-Larrán, ...
Leukemia research 35 (8), 1014-1019, 2011
692011
Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene
M Diaz-Beya, A Navarro, G Ferrer, T Diaz, B Gel, M Camos, M Pratcorona, ...
Leukemia 27 (3), 595-603, 2013
662013
Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas. Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden …
M Pratcorona, S Brunet, J Nomdedéu, JM Ribera, M Tormo, R Duarte, ...
Blood 121 (14), 2734-2738, 2013
632013
Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site
M Gaetani, S Mootien, S Harper, PG Gallagher, DW Speicher
Blood, The Journal of the American Society of Hematology 111 (12), 5712-5720, 2008
552008
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors
S Montoto, A Lopez-Guillermo, A Ferrer, M Camós, A Alvarez-Larran, ...
Annals of oncology 13 (4), 523-530, 2002
552002
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
B Barneda-Zahonero, O Collazo, A Azagra, I Fernández-Duran, ...
Cell death & disease 6 (2), e1635-e1635, 2015
522015
The system can't perform the operation now. Try again later.
Articles 1–20